144 related articles for article (PubMed ID: 25679135)
1. The effect of ketamine on configural facial processing.
MBSc EN; Joshua N; Morgan C; Rossell SL
J Clin Psychopharmacol; 2015 Apr; 35(2):188-91. PubMed ID: 25679135
[TBL] [Abstract][Full Text] [Related]
2. Using ketamine to model semantic deficits in schizophrenia.
Neill E; Rossell SL; McDonald S; Joshua N; Jansen N; Morgan CJ
J Clin Psychopharmacol; 2011 Dec; 31(6):690-7. PubMed ID: 22020346
[TBL] [Abstract][Full Text] [Related]
3. Acute and chronic effects of ketamine on semantic priming: modeling schizophrenia?
Stefanovic A; Brandner B; Klaassen E; Cregg R; Nagaratnam M; Bromley LM; Das RK; Rossell SL; Morgan CJ; Curran HV
J Clin Psychopharmacol; 2009 Apr; 29(2):124-33. PubMed ID: 19512973
[TBL] [Abstract][Full Text] [Related]
4. Effects of ketamine in normal and schizophrenic volunteers.
Lahti AC; Weiler MA; Tamara Michaelidis BA; Parwani A; Tamminga CA
Neuropsychopharmacology; 2001 Oct; 25(4):455-67. PubMed ID: 11557159
[TBL] [Abstract][Full Text] [Related]
5. Nicotine fails to attenuate ketamine-induced cognitive deficits and negative and positive symptoms in humans: implications for schizophrenia.
D'Souza DC; Ahn K; Bhakta S; Elander J; Singh N; Nadim H; Jatlow P; Suckow RF; Pittman B; Ranganathan M
Biol Psychiatry; 2012 Nov; 72(9):785-94. PubMed ID: 22717030
[TBL] [Abstract][Full Text] [Related]
6. Does ketamine mimic aspects of schizophrenic speech?
Covington MA; Riedel WJ; Brown C; He C; Morris E; Weinstein S; Semple J; Brown J
J Psychopharmacol; 2007 May; 21(3):338-46. PubMed ID: 17591660
[TBL] [Abstract][Full Text] [Related]
7. Ketamine effects on CNS responses assessed with MEG/EEG in a passive auditory sensory-gating paradigm: an attempt for modelling some symptoms of psychosis in man.
Boeijinga PH; Soufflet L; Santoro F; Luthringer R
J Psychopharmacol; 2007 May; 21(3):321-37. PubMed ID: 17591659
[TBL] [Abstract][Full Text] [Related]
8. Effects of ketamine on brain function during response inhibition.
Steffens M; Neumann C; Kasparbauer AM; Becker B; Weber B; Mehta MA; Hurlemann R; Ettinger U
Psychopharmacology (Berl); 2018 Dec; 235(12):3559-3571. PubMed ID: 30357437
[TBL] [Abstract][Full Text] [Related]
9. Impaired facial emotion recognition in a ketamine model of psychosis.
Ebert A; Haussleiter IS; Juckel G; Brüne M; Roser P
Psychiatry Res; 2012 Dec; 200(2-3):724-7. PubMed ID: 22776754
[TBL] [Abstract][Full Text] [Related]
10. Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers.
Gouzoulis-Mayfrank E; Heekeren K; Neukirch A; Stoll M; Stock C; Obradovic M; Kovar KA
Pharmacopsychiatry; 2005 Nov; 38(6):301-11. PubMed ID: 16342002
[TBL] [Abstract][Full Text] [Related]
11. Neuronal correlates of visual and auditory alertness in the DMT and ketamine model of psychosis.
Daumann J; Wagner D; Heekeren K; Neukirch A; Thiel CM; Gouzoulis-Mayfrank E
J Psychopharmacol; 2010 Oct; 24(10):1515-24. PubMed ID: 19304859
[TBL] [Abstract][Full Text] [Related]
12. Haloperidol counteracts the ketamine-induced disruption of processing negativity, but not that of the P300 amplitude.
Oranje B; Gispen-de Wied CC; Westenberg HG; Kemner C; Verbaten MN; Kahn RS
Int J Neuropsychopharmacol; 2009 Jul; 12(6):823-32. PubMed ID: 19154656
[TBL] [Abstract][Full Text] [Related]
13. Acute effects of ketamine on memory systems and psychotic symptoms in healthy volunteers.
Morgan CJ; Mofeez A; Brandner B; Bromley L; Curran HV
Neuropsychopharmacology; 2004 Jan; 29(1):208-18. PubMed ID: 14603267
[TBL] [Abstract][Full Text] [Related]
14. S-Ketamine-Induced NMDA Receptor Blockade during Natural Speech Production and Its Implications for Formal Thought Disorder in Schizophrenia: A Pharmaco-fMRI Study.
Nagels A; Cabanis M; Oppel A; Kirner-Veselinovic A; Schales C; Kircher T
Neuropsychopharmacology; 2018 May; 43(6):1324-1333. PubMed ID: 29105665
[TBL] [Abstract][Full Text] [Related]
15. Face and body perception in schizophrenia: a configural processing deficit?
Soria Bauser D; Thoma P; Aizenberg V; Brüne M; Juckel G; Daum I
Psychiatry Res; 2012 Jan; 195(1-2):9-17. PubMed ID: 21803427
[TBL] [Abstract][Full Text] [Related]
16. Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia.
Umbricht D; Schmid L; Koller R; Vollenweider FX; Hell D; Javitt DC
Arch Gen Psychiatry; 2000 Dec; 57(12):1139-47. PubMed ID: 11115327
[TBL] [Abstract][Full Text] [Related]
17. Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics.
Malhotra AK; Pinals DA; Adler CM; Elman I; Clifton A; Pickar D; Breier A
Neuropsychopharmacology; 1997 Sep; 17(3):141-50. PubMed ID: 9272481
[TBL] [Abstract][Full Text] [Related]
18. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.
Krystal JH; Karper LP; Seibyl JP; Freeman GK; Delaney R; Bremner JD; Heninger GR; Bowers MB; Charney DS
Arch Gen Psychiatry; 1994 Mar; 51(3):199-214. PubMed ID: 8122957
[TBL] [Abstract][Full Text] [Related]
19. Optimizing the glutamatergic challenge model for psychosis, using S+ -ketamine to induce psychomimetic symptoms in healthy volunteers.
Kleinloog D; Uit den Boogaard A; Dahan A; Mooren R; Klaassen E; Stevens J; Freijer J; van Gerven J
J Psychopharmacol; 2015 Apr; 29(4):401-13. PubMed ID: 25693889
[TBL] [Abstract][Full Text] [Related]
20. The role of configural information in facial emotion recognition in schizophrenia.
Chambon V; Baudouin JY; Franck N
Neuropsychologia; 2006; 44(12):2437-44. PubMed ID: 16806310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
